Insmed Inc (INSM) concluded trading on Thursday at a closing price of $101.74, with 3.95 million shares of worth about $401.76 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 44.43% during that period and on June 26, 2025 the price saw a loss of about -2.97%. Currently the company’s common shares owned by public are about 189.95M shares, out of which, 185.71M shares are available for trading.
Stock saw a price change of 2.29% in past 5 days and over the past one month there was a price change of 49.57%. Year-to-date (YTD), INSM shares are showing a performance of 48.68% which increased to 47.36% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $60.40 but also hit the highest price of $106.83 during that period. The average intraday trading volume for Insmed Inc shares is 3.11 million. The stock is currently trading 14.26% above its 20-day simple moving average (SMA20), while that difference is up 32.22% for SMA50 and it goes to 36.49% higher than SMA200.
Insmed Inc (NASDAQ: INSM) currently have 189.95M outstanding shares and institutions hold larger chunk of about 104.85% of that.
The stock has a current market capitalization of $19.33B and its 3Y-monthly beta is at 0.86. It has posted earnings per share of -$5.95 in the same period. It has Quick Ratio of 5.44 while making debt-to-equity ratio of 13.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for INSM, volatility over the week remained 3.56% while standing at 4.06% over the month.
Analysts are in expectations that Insmed Inc (INSM) stock would likely to be making an EPS of -1.31 in the current quarter, while forecast for next quarter EPS is -1.37 and it is -3.58 for next year. For the current quarter EPS, analysts have given the company a lowest target -1.47 which is -1.2 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -1.94 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 6.01% while it is estimated to increase by 30.10% in next year. EPS is likely to grow at an annualized rate of 47.55% for next 5-years, compared to annual growth of -13.12% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on May 13, 2025 offering a Buy rating for the stock and assigned a target price of $105 to it. Coverage by RBC Capital Mkts stated Insmed Inc (INSM) stock as an Outperform in their note to investors on February 25, 2025, suggesting a price target of $100 for the stock. On April 23, 2024, Truist Initiated their recommendations, while on February 15, 2024, Wolfe Research Initiated their ratings for the stock with a price target of $42. Stock get an Overweight rating from Wells Fargo on December 08, 2023.
